|
Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to
A multi-center team of researchers led by Children’s Hospital of Philadelphia (CHOP) has discovered a genetic signature that could help
With more people with diabetes and pre-diabetes looking for strategies to help control blood sugar, new research from the University of British
French drugmaker, Sanofi SA announced on Tuesday that will stop pouring in money to research diabetes and cardiovascular (DCV). The news came from
The Federal Aviation Administration (FAA) announced new protocols for pilots with insulin-treated diabetes, which will allow them to fly commercial
CNN reported last week that the Federal Aviation Administration (FAA) may allow pilots with insulin-treated diabetes to fly commercial airplanes. If
Novo Nordisk announced it will expand the company’s insulin affordability offering in the U.S. beginning on January 2, 2020. The news comes at
Baxter International Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Myxredlin Myxredlin (pronounced mix-RED-lin) is
Dance Biopharm recently presented phase 2 trial results for its inhaled preservative-free human insulin, Dance 501, for the treatment of Type 2
One Drop announced the expansion of their AI-powered Predictive Insights to include 8-hour blood glucose forecasts for One Drop, Mobile iOS users
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: